April 2025 – We are delighted to announce that the Kinstellar Belgrade team, in collaboration with international advisor Forvis Mazars Germany, has successfully advised Macopharma Group – GMPi, a global leader in the healthcare industry, on its acquisition of Lmb Technologie.
Macopharma has been a leader in the blood industry for over 45 years, and this acquisition is a key element of its five-year strategic plan to expand its product range and further strengthen its position in the European, American, and Middle Eastern markets.
As part of the expansion in Serbia, Lmb plans to extend its factory in Nia, by 2,500 square meters, creating 30 new jobs in addition to the existing 120 employees.
A heartfelt thank you to our dedicated team members Milan Samard~ić (Partner), Mina Srećković (Managing Associate), Đorđe Ilijaaević, and Jelisaveta Folić (Associates) for their outstanding work on this project.